Krishant Deo completed his PhD in Medicinal Chemistry at Western Sydney University. He then went on to join ANSTO as a Radiochemist, where he worked across commercial and research projects, contributing to the development of both therapeutic and diagnostic radiopharmaceuticals, and medical devices.
His expertise includes manual and automated radiolabelling techniques, with a strong emphasis on method optimisation to enhance process efficiency and reproducibility. Currently based at the University of Sydney’s Brain and Mind Centre (BMC), Krishant is leading initiatives to expand the BMCs radiochemistry platform by enhancing infrastructure, streamlining workflows and supporting collaborative research across multiple disciplines.
He aims to facilitate the transition of radiopharmaceuticals from research to preclinical and clinical applications, supporting advancements in diagnostic imaging within nuclear medicine.
Musculoskeletal and neurological conditions such as osteoporosis, Parkinson’s Disease or chronic fatigue syndrome affect 4 billion people worldwide. As populations grow and age, the prevalence of th
10 March 2026
NIF is pleased to announce that planning is underway for this year’s Annual Scientific Meeting, Australia’s flagship event for advanced imaging research and innovation. Dates: 30 July 2026, with c
05 February 2026
Neurodesk’s innovative ability to help researchers process and analyse massive neuroimaging datasets was recognised late last month at the 2025 National iAwards, presented in Adelaide. Neurodesk is
07 October 2025
Last week, a new Cima.X 3T MRI instrument was unveiled at NIF’s University of Sydney Node (Clinical Research Facility). Its powerful gradient technology allows for more detailed imaging that is fast
17 September 2025